CVE-2026-57386: Kodezen Llc Ablocks

High severity, CVSS 8.8. EPSS: 0.4% chance of exploitation in the next 30 days.

Incorrect Privilege Assignment vulnerability in Kodezen LLC aBlocks ablocks allows Privilege Escalation.This issue affects aBlocks: from n/a through < 2.9.1.

Affected products

• Kodezen Llc Ablocks: up to and including 2.9.1

Published 2026-07-13. Last modified 2026-07-13.